ST. Jude Medical PressureWire FFR Catherter

St. Jude Medical Inc., a global medical device company, announced that fractional flow reserve (FFR)-guided treatment using PressureWire was cost effective for coronary interventions when compared to the best available medical therapy. Cost utility analysis data from the FAME II trial was presented as a late-breaking clinical trial at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
DESolve Nx Pivotal Trial Bioresorbable Coronary Stent Elixir Cath Lab

Elixir Medical Corp. announced enrollment completion of the 120-patient, pivotal clinical trial evaluating the safety and efficacy of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System. The scaffold is designed to resorb in the body within one to two years after implantation and return the patients’ coronary vessel to de novo state.

The Philips IntelliSpace Portal is an advanced visualization solution designed to simplify the way radiologists work, think and care for patients by delivering on the promise of real-time radiology.

October 29, 2012 — At RSNA 2012, GE Healthcare will unveil innovations in healthcare IT, including enhancements to Centricity PACS (picture archiving and communication system) and PACS-IW. The PACS-IW system aligns advanced visualization, breast imaging and intelligent tools with a unified desktop.

Boston Scientific Corporation has received regulatory approval to market the Reliance 4-Front lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.

October 29, 2012 — Brainlab released Buzz Digital OR, a major step forward in information integration for the surgical suite. Buzz encompasses a vast spectrum, from pure DICOM viewing to complete digital operating room (OR) functionality, including video management and documentation.

Covidien announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of SilverHawk/TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities) study.

Biotronik began its European market release of BioMonitor, an implantable cardiac device designed for accurate and reliable monitoring and management of patients with atrial fibrillation (AF) or unexplained syncope.

October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc-99m) generators.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now